Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer

被引：0
|
作者：
Ylstra, B. [1 ]
Cordes, M. [1 ]
Biesma, H. D. [1 ]
Verheul, H. M. [2 ]
Neerincx, M. [2 ]
Koopman, M. [3 ]
Punt, C. J. [4 ]
Meijers, G. A. [5 ]
Murphy, V. [6 ]
Barat, A. [7 ]
Betge, J. [8 ]
Ebert, M. [8 ]
Gaiser, T. [8 ]
Fender, B. [9 ]
Klinger, R. [10 ]
Das, S. [7 ]
Smeets, D. [11 ]
Lambrechts, D. [11 ]
Byrne, A. T. [7 ]
Van Grieken, N. C. T. [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Canc Ctr Amsterdam, Dept Pathol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Canc Ctr Amsterdam, Dept Oncol, Amsterdam, Netherlands
[3] Univ Med Ctr Utrecht, Dept Oncol, Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Oncol, Amsterdam, Netherlands
[5] Antoni van Leeuwenhoek, Het Nederlands Kanker Inst, NKI AVL, Dept Pathol, Amsterdam, Netherlands
[6] ICORG, Dept Clin Res, Dublin, Ireland
[7] RCSI, Dept Physiol & Med Phys, Dublin, Ireland
[8] Univ Klinikum Mannheim, Dept Med 2, Mannheim, Germany
[9] OncoMark Ltd, Dept Res & Dev, Dublin, Ireland
[10] Univ Coll Dublin, Conway Inst, Dublin, Ireland
[11] KU Leuven VIB, Vesalius Res Ctr, Leuven, Belgium
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 69卷
关键词：
D O I：
10.1016/S0959-8049(16)32666-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
66
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [41] The cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer
    Park, Do Youn
    Kirley, Sandra D.
    Lauwers, Gregory Y.
    Mino-Kenudson, Mari
    Chung, Daniel C.
    Zukerberg, Lawrence R.
    GASTROENTEROLOGY, 2007, 132 (04) : A637 - A637
  • [42] Predictive tissue biomarkers for bevacizumab-containing therapy in metastatic colorectal cancer: an update
    Marien, Koen M.
    Croons, Valerie
    Martinet, Wim
    De Loof, Hans
    Ung, Christopher
    Waelput, Wim
    Scherer, Stefan J.
    Kockx, Mark M.
    De Meyer, Guido R. Y.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2015, 15 (03) : 399 - 414
  • [43] Response to "Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer"
    Daly, Louise E.
    Ryan, Aoife M.
    Power, Derek G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (31) : 3816 - +
  • [44] KRAS codon 12 and 13 mutations in metastatic colorectal cancer: Predictive marker in first-line bevacizumab-based chemotherapy
    Cunha Pereira, T.
    Salgueiro, F.
    Monteiro, A.
    Felix Soares, R.
    Macedo, F.
    Jacinto, P.
    Paulo, J.
    Bonito, N.
    Marques, M.
    Ribeiro, J.
    Sousa, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S163 - S164
  • [45] Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer
    Hong, Yong Sang
    Cho, Hyeon Jin
    Kim, Sun Young
    Jung, Kyung Hae
    Park, Ji Won
    Choi, Hyo Seong
    Oh, Jae Hwan
    Kim, Byung Chang
    Sohn, Dae Kyung
    Kim, Dae Yong
    Chang, Hee Jin
    BMC CANCER, 2009, 9 : 246
  • [46] Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer
    Yong Sang Hong
    Hyeon Jin Cho
    Sun Young Kim
    Kyung Hae Jung
    Ji Won Park
    Hyo Seong Choi
    Jae Hwan Oh
    Byung Chang Kim
    Dae Kyung Sohn
    Dae Yong Kim
    Hee Jin Chang
    BMC Cancer, 9
  • [47] Early 18F-FDG PET/CT as predictive marker of treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximab
    Skougaard, K.
    Nielsen, D.
    Jensen, B. Vittrup
    Pfeiffer, P.
    Hendel, H. Westergren
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S132 - S132
  • [48] Early 18F-FDG-PET/CT as a predictive marker for treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximab
    Skougaard, Kristin
    Nielsen, Dorte
    Jensen, Benny Vittrup
    Pfeiffer, Per
    Hendel, Helle Westergren
    ACTA ONCOLOGICA, 2016, 55 (9-10) : 1175 - 1182
  • [49] Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC)
    Bahl, Ankur
    Talwar, Vineet
    Sirohi, Bhawna
    Mehta, Prashant
    Arya, Devavrat
    Shrivastava, Gunjan
    Dahiya, Akhil
    Pavithran, K.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [50] Change in systemic inflammation markers and CEA levels as predictive marker for chemotherapy response and prognosis in metastatic colorectal cancer
    Kim, In-Ho
    Lee, In Hee
    Lee, Ji Eun
    Oh, Seong Taek
    Kim, Jun Ki
    Lee, Myung Ah
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345